Efflux pump inhibitors (EPIs) as new antimicrobial agents against Pseudomonas aeruginosa

Por Askoura, Momen, Mottawea, Walid, Abujamel, Turki, Taher, Ibrahim
Publicado em 2011

Defining the Vulnerable Period for Re-Establishment of Clostridium difficile Colonization after Treatment of C. difficile Infection with Oral Vancomycin or Metronidazole

Por Abujamel, Turki, Cadnum, Jennifer L., Jury, Lucy A., Sunkesula, Venkata C. K., Kundrapu, Sirisha, Jump, Robin L., Stintzi, Alain C., Donskey, Curtis J.
Publicado em 2013

Altered intestinal microbiota–host mitochondria crosstalk in new onset Crohn's disease

Por Mottawea, Walid, Chiang, Cheng-Kang, Mühlbauer, Marcus, Starr, Amanda E., Butcher, James, Abujamel, Turki, Deeke, Shelley A., Brandel, Annette, Zhou, Hu, Shokralla, Shadi, Hajibabaei, Mehrdad, Singleton, Ruth, Benchimol, Eric I., Jobin, Christian, Mack, David R., Figeys, Daniel, Stintzi, Alain
Publicado no Nat Commun (2016)

Intestinal inflammation targets cancer-inducing activity of the microbiota

Por Arthur, Janelle C., Perez-Chanona, Ernesto, Mühlbauer, Marcus, Tomkovich, Sarah, Uronis, Joshua M., Fan, Ting-Jia, Campbell, Barry J., Abujamel, Turki, Dogan, Belgin, Rogers, Arlin B., Rhodes, Jonathan M., Stintzi, Alain, Simpson, Kenneth W., Hansen, Jonathan J., Keku, Temitope O., Fodor, Anthony A., Jobin, Christian
Publicado em 2012